Cui-Fen Huang

Title: Innovations of Cui-Fen Huang in Cancer Research

Introduction

Cui-Fen Huang is a notable inventor based in Beijing, China. He has made significant contributions to the field of cancer research through his innovative work on telomerase reverse transcriptase fragments. His research focuses on the mechanisms that can lead to telomere dysfunction in cancer cells, which is crucial for developing new cancer treatments.

Latest Patents

Cui-Fen Huang holds a patent for "Telomerase reverse transcriptase fragments and uses thereof." This invention provides compositions comprising fragments of human telomerase reverse transcriptase (hTERT) that can induce telomere dysfunction in cells. The implications of this invention are profound, as it can lead to a reduction in growth and tumorigenicity in cancer cells. Additionally, the fragments have potential applications in cancer treatment and drug discovery. He has 1 patent to his name.

Career Highlights

Throughout his career, Cui-Fen Huang has been associated with prestigious institutions such as the Beijing Institute of Technology and the University of Hong Kong. His work in these institutions has allowed him to collaborate with other leading researchers and contribute to advancements in cancer research.

Collaborations

Cui-Fen Huang has worked alongside notable colleagues, including Jun Huang and Marie C M Lin. Their collaborative efforts have furthered the understanding of telomerase and its role in cancer biology.

Conclusion

Cui-Fen Huang's innovative research on telomerase reverse transcriptase fragments represents a significant advancement in cancer treatment strategies. His contributions to the field highlight the importance of continued research and innovation in combating cancer.